Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Overview of hypertension treatment

By Jon Waterfield

Calcium-channel blockersThis online CPD accompanies an article published in The Pharmaceutical Journal earlier this month on monitoring hypertension (2 October 2010, pp375–8).

Jon Waterfield, summarises the current recommendations for the treatment of hypertension and explains the rationale behind them


CPD logoSummary

In 2006, the British Hypertension Society collaborated with the National Institute for Health and Clinical Excellence to produce updated guidance on the treatment of hypertension, based on the appraisal of data from studies published since July 2004.

The guidance recommended a major change in that beta-blockers were no longer recommended as routine initial therapy because in head-to-head trials they were less effective than a comparator drugs at reducing major cardiovascular events, particularly stroke.

Instead, calcium-channel blockers, thiazide-type diuretics or angiotensin-converting enzyme inhibitors were recommended as first-line treatment.

To read the full article download the attached PDF (910K)


Check your learning



Jon Waterfield, MSc, MRPharmS
, is a principal lecturer in pharmacy practice at Leicester School of Pharmacy, De Montfort University


Case studies, patient decision aids and data-focused commentary are available on the “hypertension floor” of the National Prescribing Centre’s NPCi website.

Citation: The Pharmaceutical JournalURI: 11030111

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save

Supplementary information

Newsletter Sign-up

Get the latest emails sent to your inbox.